Compare and contrast Jane in Jane Eyre to Viola in Twelfth Night or What You Will. Be sure to consider each woman’s personality as you analyze how each one manages to navigate alone in society, how each one deals with her romantic relationship, and how each one makes independent decisions.

Compare and contrast Jane in Jane Eyre to Viola in Twelfth Night or What You Will. Be sure to consider each woman’s personality as you analyze how each one manages to navigate alone in society, how each one deals with her romantic relationship, and how each one makes independent decisions.

William Wilson, senior vice president of research, development,
and medical (R, D & M) at Pharmakon Drug Company,
received both his Ph.D. in biochemistry and his M.D. from the
University of Oklahoma. Upon completion of his residency,
Dr. Wilson joined the faculty at Harvard Medical School. He
left Harvard after five years to join the research group at
Merck & Co. Three years later, he went to Burroughs-
Wellcome as director of R, D & M, and, after eight years, Dr.
Wilson joined Pharmakon in his current position.
William Wilson has always been highly respected as a scientist,
a manager, and an individual. He has also been an outstanding
leader in the scientific community, particularly in the
effort to attract more minorities into the field.
Pharmakon concentrates its research efforts in the areas
of antivirals (with a focus on HIV), cardiovascular, respiratory,
muscle relaxants, gastrointestinal, the central nervous
system, and consumer health care (that is, nonprescription or
over-the-counter medicines). Dr. Wilson is on the board of
directors of Pharmakon and the company’s executive committee.
He reports directly to the chairman of the board and
CEO, Mr. Jarred Swenstrum.
Declining Growth
During the previous eight years, Pharmakon experienced
tremendous growth: 253 percent overall with yearly growth
ranging from 12 percent to 25 percent. During this period,
Pharmakon’s R, D & M budget grew from $79 million to
$403 million, and the number of employees rose from 1,192
to 3,273 (see Table 1). During the previous two years, however,
growth in revenue and earnings had slowed considerably.
Moreover, in the current year, Pharmakon’s revenues of
$3.55 billion and earnings before taxes of $1.12 billion were
up only 2 percent from the previous year. Furthermore, both
revenues and earnings are projected to be flat or declining for
the next five years.
The cessation of this period’s tremendous growth and
the likelihood of future decline have been brought about
principally by two causes. First, a number of Pharmakon’s
most important patents have expired and competition from
generics has begun and could continue to erode its products’
market shares. Second, as new types of health-care
delivery organizations evolve, pharmaceutical companies’
revenues and earnings will in all likelihood be adverse


 

. .

get-your-custom-paper

The post Compare and contrast Jane in Jane Eyre to Viola in Twelfth Night or What You Will. Be sure to consider each woman’s personality as you analyze how each one manages to navigate alone in society, how each one deals with her romantic relationship, and how each one makes independent decisions. appeared first on Blackboard Masters.